Cardiac arrest (CA) and
traumatic brain injury (TBI) are critical medical events associated with
high mortality and long-term disability, primarily due to
ischemia and subsequent
inflammation. Targeted temperature management (TTM), particularly
hypothermia, has proven beneficial in reducing
cell death, preserving
brain function, and mitigating
inflammation following these events. Conventional TTM methods are limited by delayed temperature reduction, poor temperature maintenance, and risks such as thromboembolism. The present invention addresses these challenges by introducing novel devices, apparatus, and systems for
extracorporeal whole blood cooling, enabling rapid, controlled induction and maintenance of therapeutic
hypothermia. By efficiently cooling the patient's
whole blood volume outside the body, the method of the present invention offers a
safer, more effective alternative to traditional methods, significantly improving patient outcomes after events such as CA and TBI. The present invention represents a promising advancement in emergency and critical care, enhancing survival and neurological
recovery in severely ill patients.